Synta Pharmaceuticals Appoints Christopher J. Logothetis, M.D., Mace
Synta Pharmaceuticals Appoints Christopher J. Logothetis, M.D., Mace L. Rothenberg, M.D., and ... Dr. Rothenberg is Ingram Professor of Cancer...
Expert Insights — CME - Dr. Mace L. Rothenberg
E-mail: Dr. Alan Menter ... E-mail: Dr. Martha Morrell. E-mail: Dr. Mace Rothenberg. E-mail: Dr. A. Oliver Sartor. E-mail: Dr. Michael...
Word Use, Language, and Translation -- mace [WULT.ORG]
Still, there is no question that the outlook for colon cancer patients has improved, said Dr. Mace L. Rothenberg of Vanderbilt-Ingram Cancer...
ABC News: Study Indicates Cancer Drugs Getting Safer
Dr. Mace Rothenberg, a Vanderbilt University cancer research specialist who was not involved in the study, called the findings "clearly good...
The Lucas Protocol
Contacts: Dr. Jeffrey Posnick Dr. Chris Attinger Georgetown University Hospital Department of Craniofacial Surgery
New Drugs on the Horizon: Matrix Metalloproteinase Inhibitors --
Dr. Mace L. Rothenberg, Vanderbilt University Medical Center, Division of Medical Oncology, Department of Medicine, 1956 The Vanderbilt Clinic...
NameTraq | Last Name: Rothenberg
Still, there is no question that the outlook for colon cancer patients has improved, said Dr. Mace L. Rothenberg of Vanderbilt-Ingram Cancer...
Sound Medicine for August 2, 2003
Dr. Mace Rothenberg, a clinical oncologist and researcher at Vanderbilt University Medical Center, discusses balancing the needs of patients...
Nashville, Tennessee - Check Dr. and MD Credentials
MD, Dr. Stephen Ross MD, Dr. Rebecca Rossello MD, Dr. Jill Rossrucker MD, Dr. James Roth MD, Dr. Bruce J Roth MD, Dr. Mace Rothenberg MD, Dr...
Ananova - Bowel cancer drug claim
Dr Mace Rothenberg from the Vanderbilt-Ingram Cancer Centre in Nashville, lead the research.
NOTE: Please contact us right away if you'd like to make any changes to your listing.
Home | Index
|
|
